| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 114.81B | 103.17B | 79.87B | 82.78B | 71.25B | 59.63B |
| Gross Profit | 36.17B | 32.23B | 26.41B | 22.81B | 19.34B | 15.08B |
| EBITDA | 27.33B | 24.15B | 19.80B | 16.94B | 13.84B | 9.37B |
| Net Income | 16.26B | 14.16B | 11.92B | 11.61B | 7.42B | 4.27B |
Balance Sheet | ||||||
| Total Assets | 217.87B | 218.19B | 188.66B | 152.52B | 136.51B | 127.48B |
| Cash, Cash Equivalents and Short-Term Investments | 40.78B | 44.92B | 47.87B | 42.02B | 30.05B | 21.51B |
| Total Debt | 93.96B | 92.46B | 79.54B | 55.66B | 51.07B | 47.52B |
| Total Liabilities | 110.20B | 112.29B | 94.25B | 68.56B | 62.06B | 57.71B |
| Stockholders Equity | 104.02B | 102.19B | 90.55B | 80.73B | 71.31B | 66.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.26B | -13.46B | 9.01B | 8.96B | 4.41B |
| Operating Cash Flow | 0.00 | -4.24B | -11.00B | 16.54B | 17.44B | 4.73B |
| Investing Cash Flow | 0.00 | -8.81B | -4.21B | -6.68B | -9.38B | 3.45B |
| Financing Cash Flow | 0.00 | 9.48B | 20.99B | 2.04B | 443.00M | -4.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥133.18B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
73 Outperform | ¥4.63T | 16.16 | 9.64% | 0.97% | 0.49% | 12.19% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥1.47T | 6.06 | 13.29% | 3.25% | 45.15% | 19.80% | |
65 Neutral | ¥805.89B | 12.53 | 10.59% | 2.94% | -19.09% | 16.31% | |
63 Neutral | ¥218.44B | 21.96 | 16.39% | 2.38% | 7.21% | 112.45% | |
57 Neutral | ¥979.03B | 17.83 | 7.40% | 3.68% | 3.52% | -17.58% |